MetLife Investment Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $732K | Buy |
63,171
+58,204
| +1,172% | +$674K | ﹤0.01% | 1480 |
|
|
2025
Q1 | $43.4K | Buy |
4,967
+4
| +0.1% | +$35 | ﹤0.01% | 2701 |
|
|
2024
Q4 | $71.3K | Sell |
4,963
-33
| -0.7% | -$474 | ﹤0.01% | 2707 |
|
|
2024
Q3 | $113K | Sell |
4,996
-100
| -2% | -$2.26K | ﹤0.01% | 2578 |
|
|
2024
Q2 | $99.1K | Sell |
5,096
-486
| -9% | -$9.45K | ﹤0.01% | 2609 |
|
|
2024
Q1 | $209K | Buy |
5,582
+17
| +0.3% | +$638 | ﹤0.01% | 2181 |
|
|
2023
Q4 | $311K | Sell |
5,565
-77
| -1% | -$4.31K | ﹤0.01% | 1971 |
|
|
2023
Q3 | $233K | Buy |
5,642
+3
| +0.1% | +$124 | ﹤0.01% | 2117 |
|
|
2023
Q2 | $315K | Buy |
5,639
+445
| +9% | +$24.8K | ﹤0.01% | 1982 |
|
|
2023
Q1 | $290K | Buy |
5,194
+13
| +0.3% | +$725 | ﹤0.01% | 1987 |
|
|
2022
Q4 | $189K | Sell |
5,181
-130
| -2% | -$4.74K | ﹤0.01% | 2280 |
|
|
2022
Q3 | $151K | Buy |
5,311
+61
| +1% | +$1.74K | ﹤0.01% | 2458 |
|
|
2022
Q2 | $238K | Sell |
5,250
-220
| -4% | -$9.96K | ﹤0.01% | 2193 |
|
|
2022
Q1 | $416K | Buy |
+5,470
| New | +$416K | ﹤0.01% | 1888 |
|
|
2021
Q2 | – | Sell |
-3,886
| Closed | -$703K | – | 2487 |
|
|
2021
Q1 | $703K | Buy |
+3,886
| New | +$703K | 0.01% | 1329 |
|
|
2020
Q4 | – | Sell |
-4,918
| Closed | -$613K | – | 2313 |
|
|
2020
Q3 | $613K | Buy |
+4,918
| New | +$613K | 0.01% | 1265 |
|